SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for PALISADE BIO, INC. (PALI) (CIK 0001357459) (PALI) — Apr 13, 2011

PALISADE BIO, INC. (PALI) (CIK 0001357459)
Date: April 13, 2011 · CIK: 0001357459 · Accession: 0000000000-11-023246

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-173221

Date
April 13, 2011
Author
Jeffrey P. Riedler
Form
UPLOAD
Company
PALISADE BIO, INC. (PALI) (CIK 0001357459)

Letter

April 13, 2011 I. Richard Garr President and Chief Executive Officer Neuralstem, Inc. 9700 Great Seneca Highway Rockville, Maryland 20850

Re: Neuralstem, Inc. Registration Statement on Form S-3 Filed March 31, 2011 File No. 333-173221

Dear Mr. Garr: We have limited our review of your regist ration statement to your incorporation of certain documents by reference. Please amend this section to include the Form 8-K filed February 15, 2011. Please respond to this letter by amending your registration statement and providing the requested information. Where you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your re gistration statement and the information you provide in response to these comments, we may have additional comments.

We urge all persons who are responsible for th e accuracy and adequacy of the disclosure in the filing to be certain that the filing incl udes the information the Securities Act of 1933 and all applicable Securities Act rules require. Since the company and its management are in possession of all facts relating to a company’s disc losure, they are responsible for the accuracy and adequacy of the disclosures they have made. Notwithstanding our comments, in the event you request acceleration of the effective date of the pending registration statement please pr ovide a written statement from the company acknowledging that:

• should the Commission or the staff, acting purs uant to delegated authority, declare the filing effective, it does not foreclose the Co mmission from taking any action with respect to the filing;

I. Richard Garr Neuralstem, Inc. April 13, 2011 Page 2

• the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

• the company may not assert staff comments a nd the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Please refer to Rules 460 and 461 regarding re quests for acceleration. We will consider a written request for acceleration of the effective date of the regi stration statement as confirmation of the fact that those reques ting acceleration are aware of thei r respective responsibilities under the Securities Act of 1933 and the Securities Excha nge Act of 1934 as they relate to the proposed public offering of the securities specified in th e above registration stat ement. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. Please contact Michael Rosenthall at 202-551-3674 or me at 202-551-3715 with any other questions. Sincerely, Jeffrey P. Riedler Assistant Director

Show Raw Text
April 13, 2011
 I. Richard Garr President and Chief Executive Officer Neuralstem, Inc. 9700 Great Seneca Highway
Rockville, Maryland 20850

Re: Neuralstem, Inc.
  Registration Statement on Form S-3
Filed March 31, 2011
  File No. 333-173221

Dear Mr. Garr:
 We have limited our review of your regist ration statement to your incorporation of
certain documents by reference.  Please amend this section to include the Form 8-K filed
February 15, 2011.
 Please respond to this letter by amending your registration statement and providing the
requested information.  Where you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
 After reviewing any amendment to your re gistration statement and the information you
provide in response to these comments, we may have additional comments.

We urge all persons who are responsible for th e accuracy and adequacy of the disclosure
in the filing to be certain that the filing incl udes the information the Securities Act of 1933 and
all applicable Securities Act rules require.  Since the company and its management are in
possession of all facts relating to a company’s disc losure, they are responsible for the accuracy
and adequacy of the disclosures they have made.
Notwithstanding our comments, in the event you request acceleration of  the effective date
of the pending registration statement please pr ovide a written statement from the company
acknowledging that:

• should the Commission or the staff, acting purs uant to delegated authority, declare the
filing effective, it does not foreclose the Co mmission from taking any action with respect
to the filing;

I. Richard Garr Neuralstem, Inc.  April 13, 2011 Page 2

• the action of the Commission or the staff, acting pursuant to delegated authority, in
declaring the filing effective, does not relieve the company from its full responsibility for
the adequacy and accuracy of the disclosure in the filing; and

• the company may not assert staff comments a nd the declaration of effectiveness as a
defense in any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.  Please refer to Rules 460 and 461 regarding re quests for acceleration.  We will consider a
written request for acceleration of  the effective date of the regi stration statement as confirmation
of the fact that those reques ting acceleration are aware of thei r respective responsibilities under
the Securities Act of 1933 and the Securities Excha nge Act of 1934 as they relate to the proposed
public offering of the securities specified in th e above registration stat ement.  Please allow
adequate time for us to review any amendment prior to the requested effective date of the
registration statement.
 Please contact Michael Rosenthall at 202-551-3674 or me at 202-551-3715 with any
other questions.
Sincerely,
       Jeffrey P. Riedler
Assistant Director